Track the キッセイ薬品工業株式会社 stock price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, キッセイ薬品工業株式会社 has logged 3 public disclosures. Market capitalisation: €177.4bn. The latest transaction was reported on 20 May 2024 (Holding update). Among the most active insiders: The Hachijuni Bank, Ltd.. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Kissei Pharmaceutical Co., Ltd. is a Japanese company operating in the healthcare and pharmaceutical sector. It focuses on the research, development, and marketing of innovative medicines.